BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 31083551)

  • 1. Drug-Induced Mitochondrial Toxicity in the Geriatric Population: Challenges and Future Directions.
    Will Y; Shields JE; Wallace KB
    Biology (Basel); 2019 May; 8(2):. PubMed ID: 31083551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Important aspects of geriatric pharmacotherapy].
    Borchelt M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 May; 48(5):593-8. PubMed ID: 15887071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polypharmacy and patterns of prescription medication use among cancer survivors.
    Murphy CC; Fullington HM; Alvarez CA; Betts AC; Lee SJC; Haggstrom DA; Halm EA
    Cancer; 2018 Jul; 124(13):2850-2857. PubMed ID: 29645083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of pharmacological agents on mitochondrial function: a growing opportunity?
    Stoker ML; Newport E; Hulit JC; West AP; Morten KJ
    Biochem Soc Trans; 2019 Dec; 47(6):1757-1772. PubMed ID: 31696924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication use in older patients and age-blind approach: narrative literature review (insufficient evidence on the efficacy and safety of drugs in older age, frequent use of PIMs and polypharmacy, and underuse of highly beneficial nonpharmacological strategies).
    Fialová D; Laffon B; Marinković V; Tasić L; Doro P; Sόos G; Mota J; Dogan S; Brkić J; Teixeira JP; Valdiglesias V; Costa S;
    Eur J Clin Pharmacol; 2019 Apr; 75(4):451-466. PubMed ID: 30610276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of in Vitro Mitochondrial Toxicity Assays and Physicochemical Properties for Prediction of Organ Toxicity Using 228 Pharmaceutical Drugs.
    Rana P; Aleo MD; Gosink M; Will Y
    Chem Res Toxicol; 2019 Jan; 32(1):156-167. PubMed ID: 30525499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States.
    Stepan AF; Walker DP; Bauman J; Price DA; Baillie TA; Kalgutkar AS; Aleo MD
    Chem Res Toxicol; 2011 Sep; 24(9):1345-410. PubMed ID: 21702456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drug-drug interactions.
    Tulner LR; Kuper IM; Frankfort SV; van Campen JP; Koks CH; Brandjes DP; Beijnen JH
    Am J Geriatr Pharmacother; 2009 Apr; 7(2):93-104. PubMed ID: 19447362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication adherence among geriatric outpatients prescribed multiple medications.
    Tsai KT; Chen JH; Wen CJ; Kuo HK; Lu IS; Chiu LS; Wu SC; Chan DC
    Am J Geriatr Pharmacother; 2012 Feb; 10(1):61-8. PubMed ID: 22264853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies to reduce late-stage drug attrition due to mitochondrial toxicity.
    Dykens JA; Marroquin LD; Will Y
    Expert Rev Mol Diagn; 2007 Mar; 7(2):161-75. PubMed ID: 17331064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of pharmacotherapy in geriatric patients after performing complete geriatric assessment at a diagnostic day clinic.
    Frankfort SV; Tulner LR; van Campen JP; Koks CH; Beijnen JH
    Clin Drug Investig; 2006; 26(3):169-74. PubMed ID: 17163248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interactions of some commonly consumed drugs with mitochondrial adaptations to exercise.
    Robinson MM; Hamilton KL; Miller BF
    J Appl Physiol (1985); 2009 Jul; 107(1):8-16. PubMed ID: 19423832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating drug-induced mitochondrial toxicity: a biosensor to increase drug safety?
    Pereira CV; Moreira AC; Pereira SP; Machado NG; Carvalho FS; Sardão VA; Oliveira PJ
    Curr Drug Saf; 2009 Jan; 4(1):34-54. PubMed ID: 19149524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central role of mitochondria in drug-induced liver injury.
    Pessayre D; Fromenty B; Berson A; Robin MA; Lettéron P; Moreau R; Mansouri A
    Drug Metab Rev; 2012 Feb; 44(1):34-87. PubMed ID: 21892896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicity assessments of nonsteroidal anti-inflammatory drugs in isolated mitochondria, rat hepatocytes, and zebrafish show good concordance across chemical classes.
    Nadanaciva S; Aleo MD; Strock CJ; Stedman DB; Wang H; Will Y
    Toxicol Appl Pharmacol; 2013 Oct; 272(2):272-80. PubMed ID: 23811329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.